These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28109119)

  • 1. Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway.
    Hadden C; Fahmi T; Cooper A; Savenka AV; Lupashin VV; Roberts DJ; Maroteaux L; Hauguel-de Mouzon S; Kilic F
    J Cell Physiol; 2017 Dec; 232(12):3520-3529. PubMed ID: 28109119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway of Maternal Serotonin to the Human Embryo and Fetus.
    Kliman HJ; Quaratella SB; Setaro AC; Siegman EC; Subha ZT; Tal R; Milano KM; Steck TL
    Endocrinology; 2018 Apr; 159(4):1609-1629. PubMed ID: 29381782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Changes in the serotonin transporter (Slc6a4) knockout mouse suggest a role for serotonin in controlling nutrient acquisition.
    Mao J; Kinkade JA; Bivens NJ; Roberts RM; Rosenfeld CS
    Placenta; 2021 Nov; 115():158-168. PubMed ID: 34649169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
    Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential patterning of genes involved in serotonin metabolism and transport in extra-embryonic tissues of the mouse.
    Wu HH; Choi S; Levitt P
    Placenta; 2016 Jun; 42():74-83. PubMed ID: 27238716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter.
    Kim DK; Tolliver TJ; Huang SJ; Martin BJ; Andrews AM; Wichems C; Holmes A; Lesch KP; Murphy DL
    Neuropharmacology; 2005 Nov; 49(6):798-810. PubMed ID: 16183083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression.
    Dawson N; Ferrington L; Lesch KP; Kelly PA
    Eur Neuropsychopharmacol; 2011 Jan; 21(1):117-28. PubMed ID: 21093224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models.
    Araragi N; Lesch KP
    Curr Drug Targets; 2013 May; 14(5):549-70. PubMed ID: 23547810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.
    Li Y; Cooper A; Odibo IN; Ahmed A; Murphy P; Koonce R; Dajani NK; Lowery CL; Roberts DJ; Maroteaux L; Kilic F
    J Biol Chem; 2016 Apr; 291(18):9657-65. PubMed ID: 26921319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of placental serotonin transporter and 5-HT 2A receptor in normal and gestational diabetes mellitus pregnancies.
    Viau M; Lafond J; Vaillancourt C
    Reprod Biomed Online; 2009 Aug; 19(2):207-15. PubMed ID: 19712556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the function of the serotonin transporter in the vasculature of male and female rats.
    Linder AE; Davis RP; Burnett R; Watts SW
    Clin Exp Pharmacol Physiol; 2011 May; 38(5):314-22. PubMed ID: 21371073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake.
    Li Y; Hadden C; Singh P; Mercado CP; Murphy P; Dajani NK; Lowery CL; Roberts DJ; Maroteaux L; Kilic F
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):E5697-705. PubMed ID: 25512553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Transporter Deficiency Induces Metabolic Alterations in the Ileal Mucosa.
    Calzadilla N; Jayawardena D; Qazi A; Sharma A; Mongan K; Comiskey S; Eathara A; Saksena S; Dudeja PK; Alrefai WA; Gill RK
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state.
    Kim K; Oh CM; Ohara-Imaizumi M; Park S; Namkung J; Yadav VK; Tamarina NA; Roe MW; Philipson LH; Karsenty G; Nagamatsu S; German MS; Kim H
    Endocrinology; 2015 Feb; 156(2):444-52. PubMed ID: 25426873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.
    Muller CL; Anacker AM; Rogers TD; Goeden N; Keller EH; Forsberg CG; Kerr TM; Wender C; Anderson GM; Stanwood GD; Blakely RD; Bonnin A; Veenstra-VanderWeele J
    Neuropsychopharmacology; 2017 Jan; 42(2):427-436. PubMed ID: 27550733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-beta1 signalling.
    Pavone LM; Spina A; Rea S; Santoro D; Mastellone V; Lombardi P; Avallone L
    J Mol Cell Cardiol; 2009 Nov; 47(5):691-7. PubMed ID: 19646988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.
    Margolis KG; Li Z; Stevanovic K; Saurman V; Israelyan N; Anderson GM; Snyder I; Veenstra-VanderWeele J; Blakely RD; Gershon MD
    J Clin Invest; 2016 Jun; 126(6):2221-35. PubMed ID: 27111230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.
    Gwynne WD; Hallett RM; Girgis-Gabardo A; Bojovic B; Dvorkin-Gheva A; Aarts C; Dias K; Bane A; Hassell JA
    Oncotarget; 2017 May; 8(19):32101-32116. PubMed ID: 28404880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction.
    Ranzil S; Ellery S; Walker DW; Vaillancourt C; Alfaidy N; Bonnin A; Borg A; Wallace EM; Ebeling PR; Erwich JJ; Murthi P
    Placenta; 2019 Sep; 84():74-83. PubMed ID: 31176514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.